2025 second_quarter Filing
Q2Income
$30K
Filed
July 21, 2025
Lobbying Activities (1)
Health Issues
View allGeneral Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.
Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)Office of Natl Drug Control Policy (NDCP)Office of Science & Technology Policy (OSTP)Defense, Dept of (DOD)Executive Office of the President (EOP)SENATE
Lobbyists (2)
MARK F LINDSAY
US House Staff
ERIK DELL